Ignite Creation Date:
2024-05-05 @ 11:53 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00152191
Status:
COMPLETED
Last Update Posted:
2011-07-07
First Post:
2005-09-07
Brief Title:
A Randomized Controlled Study of Postoperative Adjuvant Therapy of Uracil-tegafur UFT Compared With CyclophosphamideMethotrexate5-fluorouracil CMF in Breast Cancer NSAS-BC
Sponsor:
Organization:
Taiho Pharmaceutical Co Ltd
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
1300
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE3 |
Observational Models:
Time Perspective List:
Who Masked List: